Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Neurophth’s ADOA Candidate Drug Gets Australian Approval
Neurophth Therapeutics announced that the Australian Therapeutic Goods Administration (TGA) has granted registration and approval for its candidate drug, NFS-05, for clinical trials aimed at addressing autosomal dominant optic atrophy (ADOA). According to a company news release, ADOA is an…
Overview of Ptosis Surgery | OBN
Ptosis is when the upper eyelid droops over the eye. The eyelid may droop just a little, or so much that it covers the pupil (the black dot at the center of your eye that lets light in). Ptosis can…
Types of Custom Contact Lenses
Custom contact lenses are created especially for you and precisely fit your eyes. These are mainly applied when conventional contact lenses are irritating you and cause discomfort every time you use them. These are extremely convenient if you have astigmatism…
Bausch + Lomb Introduces Dry Eye Drug Miebo in the U.S.
Bausch + Lomb has officially launched Miebo (perfluorohexyloctane ophthalmic solution) for the treatment of dry eye disease (DED) in the United States. Earlier in May, Bausch + Lomb and Novaliq received FDA approval for Miebo, marking it as the first…
Alcon Introduces Launch Of AcrySof IQ Vivity
Development of active glasses for mitigating presbyopia has become an active area of research, facilitated by the miniaturization of focus-tunable lenses as well as the increased processing power of modern computers. Alcon the global leader in eye care dedicated to…
Ophthalmic Market Projected to Reach $532.8M by 2026
The global ophthalmic sutures market size is expected to reach USD 532.8 million by 2026, expanding at a CAGR of 6.4% over the forecast period, according to a new report by Grand View research, Inc. Key factors driving the market…
Cataract Journey and Medical Staff’s Role in Patient Care
Cataract surgery is the most frequently performed operative procedure worldwide, typically concludes with the implantation of an artificial intraocular lens (IOL) to correct aphakia (absence of the crystalline lens). The surgery—which involves removing the eye’s clouded lens and replacing it…
FDA Approves Lupin’s Bromfenac Ophthalmic Solution
Lupin Limited, a global pharmaceutical company, has officially received approval from the US FDA for its Abbreviated New Drug Application for Bromfenac Ophthalmic Solution, 0.09%. This approval allows Lupin to introduce a generic counterpart to Bausch & Lomb Inc.’s Bromday…
MHRA Issues Warning for Nidek’s EyeCee Preloaded IOLs
The Medicines and Healthcare products Regulatory Agency (MHRA) has recently issued a National Patient Safety Alert due to reports of increased intraocular pressure in patients recently implanted with EyeCee One preloaded and EyeCee One Crystal preloaded intraocular lenses (IOLs), which…
Caeregen Therapeutics Secures $1.4M Research Grant
Caeregen Therapeutics announced that it has received a $1.4 million Phase 2 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) and National Eye Institute (NEI). The grant has been awarded to further the advancement of…